https://www.patlynk.com/es/trial/NCT00003752
A Multicenter Phase II Evaluation of Targretin (Bexarotene) Capsules in Patients With Advanced...
OBJECTIVES: I. Compare the efficacy of oral bexarotene (LGD1069) at two different dose levels in patients with advanced breast cancer. II. Assess the safety and
phase iimulticenterevaluationtargretinbexarotene